CN1997659A - D－加碳－17－氯－16(17)－烯甾体 - Google Patents

D－加碳－17－氯－16(17)－烯甾体 Download PDF

Info

Publication number
CN1997659A
CN1997659A CNA2005800188931A CN200580018893A CN1997659A CN 1997659 A CN1997659 A CN 1997659A CN A2005800188931 A CNA2005800188931 A CN A2005800188931A CN 200580018893 A CN200580018893 A CN 200580018893A CN 1997659 A CN1997659 A CN 1997659A
Authority
CN
China
Prior art keywords
chloro
beta
ketone
diene
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800188931A
Other languages
English (en)
Chinese (zh)
Inventor
斯文·林
拉尔夫·维尔瓦
京特·考夫曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of CN1997659A publication Critical patent/CN1997659A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CNA2005800188931A 2004-04-08 2005-04-07 D－加碳－17－氯－16(17)－烯甾体 Pending CN1997659A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004018441.0 2004-04-08
DE102004018441A DE102004018441B4 (de) 2004-04-08 2004-04-08 D-Homo-17-chlor-16(17)en Steroide

Publications (1)

Publication Number Publication Date
CN1997659A true CN1997659A (zh) 2007-07-11

Family

ID=34966688

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005800188931A Pending CN1997659A (zh) 2004-04-08 2005-04-07 D－加碳－17－氯－16(17)－烯甾体

Country Status (18)

Country Link
EP (1) EP1735331A1 (de)
KR (1) KR20070007910A (de)
CN (1) CN1997659A (de)
AR (1) AR048536A1 (de)
AU (1) AU2005231970A1 (de)
CA (1) CA2563541A1 (de)
CR (1) CR8736A (de)
DE (1) DE102004018441B4 (de)
EA (1) EA200601842A1 (de)
EC (1) ECSP066973A (de)
GT (1) GT200500084A (de)
MX (1) MXPA06012849A (de)
NO (1) NO20065126L (de)
PA (1) PA8629401A1 (de)
SV (1) SV2005002076A (de)
TW (1) TW200603812A (de)
WO (1) WO2005097819A1 (de)
ZA (1) ZA200609275B (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4788218A (en) * 1984-05-21 1988-11-29 Sri International 17 a β-hydroxy-7 α-methyl-d-homo-19-norandrost-4,16-diene-3-one and the 17-esters thereof: methods of preparation and uses
DE4042005A1 (de) * 1990-12-22 1992-06-25 Schering Ag D-homo-(16-en)-11(beta)-aryl-4-estrene
DK0640294T4 (da) * 1993-08-21 2000-04-03 Nestle Sa Fremstilling af et krydderi
DE10151365A1 (de) * 2001-10-17 2003-04-30 Schering Ag 17-Chlor-D-Homosteroide als selektive Estrogenrezeptorantagonisten

Also Published As

Publication number Publication date
ECSP066973A (es) 2006-12-29
SV2005002076A (es) 2005-12-06
CA2563541A1 (en) 2005-10-20
TW200603812A (en) 2006-02-01
DE102004018441B4 (de) 2007-12-20
ZA200609275B (en) 2009-08-26
CR8736A (es) 2007-08-28
AR048536A1 (es) 2006-05-03
PA8629401A1 (es) 2006-07-03
EP1735331A1 (de) 2006-12-27
EA200601842A1 (ru) 2007-04-27
MXPA06012849A (es) 2007-01-26
WO2005097819A1 (de) 2005-10-20
NO20065126L (no) 2007-01-04
GT200500084A (es) 2006-03-24
KR20070007910A (ko) 2007-01-16
DE102004018441A1 (de) 2005-11-03
AU2005231970A1 (en) 2005-10-20

Similar Documents

Publication Publication Date Title
TW499434B (en) Antigestagenically active steroids with a fluorinated 17Α-alkyl chain
KR102526631B1 (ko) 스테로이드 fxr 조절인자를 제조하기 위한 중간체로서의 6-알킬-7-하이드록시-4-엔-3-온 스테로이드
KR102526632B1 (ko) 스테로이드 FXR 조절인자를 제조하기 위한 중간체로서의 5β-6-알킬-7-하이드록시-3-온 스테로이드
KR102546748B1 (ko) 스테로이드 FXR 조절인자를 제조하기 위한 중간체로서의 6α-알킬-3,7-다이온 스테로이드
KR102527821B1 (ko) 스테로이드 FXR 조절인자를 제조하기 위한 중간체로서의 6α-알킬-6,7-다이온 스테로이드
CN101652142B (zh) 盐皮质激素受体拮抗剂
JP2911553B2 (ja) １１β―アリール―４―エストレン、その製法、中間生成物及び新規化合物を含有する抗ゲスタゲン及び抗グルココルチコイド作用を有する製薬学的製済
JPS6069096A (ja) 新規ステロイド
US3200113A (en) 7-cyano steroids and derivatives thereof
MXPA01008065A (es) Derivados del 16-hidroxiestratrieno empleados como estrogenos selelctivos.
JPS5931800A (ja) １９−チオ−アンドロスタン誘導体
JPS6323895A (ja) 新規な６−もしくは７−メチレンアンドロスタ−１，４−ジエン−３，１７−ジオン誘導体およびその製造方法
CN101863947A (zh) 一种地诺孕素的合成方法
CN100354299C (zh) 在11位带有烃取代基的非芳香族雌激素甾族化合物
CN101434632A (zh) 一种3α,7α-二羟基-5β-胆烷酸的制备方法
PT1226155E (pt) 18-nor-esteróides como estrogénios selectivamente activos
US3210388A (en) 13alpha-fluoro-17beta-methyl-18-nor steroids
EP1322660B1 (de) 17alpha-fluoralkylsteroide, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
US5446178A (en) Process for preparing 19,11β-bridged steroids
JP2002541153A (ja) 経口活性アンドロゲン
CN103319558B (zh) 甾体化合物及其制备方法和用途
HK1104560A (en) D-homo-17-chloro-16(17)en steroids
US20050234111A1 (en) D-homo-17-chlor-16(17)-ene steroids
MXPA06012849A (es) D-homo-17-cloro-16(17)eno esteroides.
US7388003B2 (en) Δ15-D-Homosteroids with androgenic action

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1104560

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20070711

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1104560

Country of ref document: HK